Chrissy Metz Opens Up About Her Decision to Begin GLP-1 Medication After Years of Hesitation
The actress explains the personal reasons that moved her from long-standing skepticism to beginning a GLP-1 treatment.
Chrissy Metz, the actress widely recognised for her role on the long-running television series This Is Us, has shared the reasoning behind her decision to begin a GLP-1 medication after years of public hesitation. In a recent interview, Metz described the moment and mindset that led her to reconsider her position on the treatment, which has gained widespread attention for its role in weight management.
From doubt to a personal decision
Metz explained that her earlier skepticism stemmed from a desire to handle health changes through traditional lifestyle adjustments rather than medication. Over time, conversations with medical professionals and a reassessment of her own wellbeing shifted that perspective. She emphasised that the choice was personal, taken after careful thought rather than outside pressure.
Broader conversation around GLP-1 treatments
GLP-1 receptor agonists, originally developed for type 2 diabetes, have become a prominent topic in discussions about weight loss and metabolic health. Metz's remarks arrive as more public figures openly discuss their experiences with the medications, contributing to a wider cultural dialogue.
Nutrition experts note that any weight-management approach benefits from sustainable habits alongside medical guidance. Readers interested in the broader picture can explore how long-term lifestyle shifts support abdominal fat reduction and why calorie counting alone may undermine weight loss efforts. Some individuals combine treatment with structured eating plans, such as a dietitian-designed Mediterranean meal plan aimed at higher energy.
What Metz hopes others take away
Metz stated that she hopes her openness encourages others to approach the topic without shame and to consult qualified healthcare providers before making decisions. She framed the medication as one tool among many, not a substitute for personalised medical advice.